• The Journal of the Korea institute of electronic communication sciences
• /
• v.9 no.1
• /
• pp.61-66
• /
• 2014

As a key technology of U-health, RFID can be applied to the hospitals in a variety of cases such as patient tracking, medical instrument management, and so on. However, adoption of RFID in healthcare does not reach expectations because of huge cost. Exact estimation of cost and effectiveness will boost adoption of RFID in healthcare. This study proposes a novel simulation technique to evaluate cost and effectiveness of RFID in hospital environment. To do this, this study proposes a technique for modeling patients' movements in a hospital. Based on the model, this study provides how to obtain tag event dataset by means of simulating identifications of RFID tags that are attached to patients.

• Journal of the Korea Convergence Society
• /
• v.8 no.2
• /
• pp.53-62
• /
• 2017

This study was to find the factors influencing satisfaction of Korean medical tour services of Chinese college students. Structured questionnaire was developed to collect data. The data were collected from the 175 students between May 1 and May 15 in 2015 in an international college in China. The expectations and the evaluations on the Korean medical tour services were compare by t-test. To find the factors influencing satisfaction on Korean medical tour services, diverse linear regression models were estimated. According to the best fit regression model, technologies, quality of medical tour services, and health care cost significantly and positively influenced satisfaction on the Korean medical tour services. The results of the study suggested that we need to prepare marketing strategies to improve understandings on Korean medical tour services for the Chinese college students. Improvement of technology, improvement of quality of health service, and setting of reasonable price are important to attract more Chinese patients to Korea.

• Korea Journal of Hospital Management
• /
• v.26 no.3
• /
• pp.84-99
• /
• 2021

Purposes: 우리나라 공공의료기관들의 경영실적 보고에 따르면 대부분의 공공의료기관들이 만성적자로 인한 경영난 문제를 겪고 있는 실정이다. 이는 공공의료서비스 제공 등이 주요 원인이겠지만 그럼에도 공공의료기관들의 경영효율화 문제는 지속적으로 지적되고 있음은 공공연한 사실이다. 이에 본 연구는 고정비 성격이 강한 인적자원관리비용과 경영성과 간의 관계를 분석하여 공공의료기관의 경영성과 개선을 위한 경영적 함의를 제공하고자 하였다. Methodology: 분석자료는 2014년부터 2019년까지 39개 지역거점 공공병원의 재무자료를 이용하였고, STATA SE 12.0을 사용하여 다중회귀분석과 패널회귀분석을 실시하였다. Findings: 다중회귀분석을 통한 단면연구 결과에서는 인건비가 높을수록 경영성과가 높은 경향을(2014년 의료수익:1.523/ 2015년 의료수익: 2.002, 의료수익의료이익률: 0.002/ 2016년 의료수익: 1.223) 보였으나 패널회귀분석을 통한 종단연구 결과에서는 복리후생비가 높을수록 경영성과가 의미있게 높은 경향을(의료수익: 3.232582/ 의료수익의료이익률: 0.0014502) 보였다. 이는 인건비는 경영성과에 단기적인 효과가 있는 반면 복리후생비는 경영성과에 장기적인 효과가 있음을 반영하는 것이라고 볼 수 있다. Practical Implication: 본 연구는 이러한 결과를 기반으로 장기적인 효과가 있는 복리후생비의 중요성을 제시하고, 공공의료기관의 경영성과에 영향을 미치는 인건비와 복리후생비의 특성 파악을 통하여 효과적인 인적자원관리방법을 위한 경영적 함의를 도출하였다는 점에서 의의가 있겠다.

• The Korean Society of Law and Medicine
• /
• v.5 no.2
• /
• pp.111-147
• /
• 2004

• Journal of Korean Society of Transportation
• /
• v.16 no.1
• /
• pp.59-78
• /
• 1998

'90년대에 들어서면서 급속한 경제성장과 함께 자동차수가 급증하여 '97년에는 1.000만대를 돌파 하였다. 자동차수의 증가와 함께 교통사고도 나날이 늘어 '96년에는 사망자가 12,600여명에 이르렀다. 교 통사고는 막대한 인명피해와 함께 사회적으로 많은 비용을 소모한다. 교통사고로 인한 사회적 비용의 추정은 교통안전사업의 효과분석 및 기타 교통관련사업에서 꼭 필요한 자료이다. 이제까지 국내에서 수 행된 교통사고비용은 1년간의 전체 사고비용만을 추정하고 사고등급별 사고건당 사고비용은 도출하지 못하였다. 이에 본연구는 교통관련사업에서 꼭필요한 자료이다. 이제까지 국내에서 수행된 교통사고 비 용은 1년간의 전체 사고비용만을 추정하고 사고등급별 사고건당 사고비용은 도출하지 못하였다. 이에 본 연구는 교통관련사업에 필수적인 사고심각도에 따른 교통사고비용을 도출하려한다. 교통사고비용을 산출하는 대표적인 방법에는 총생산손실법과 개인선호성법이 있으나 본연구에서는 총생산손실법을 이용 하였다. 교통사고비용 항목은 사고로 인한 생산손실비용, 의료비용, 차량수리비용, 행정비용 및 PGS(Pain, Grief & Suffering) 비용으로 구분된다. 이중에서 PGS비용은 국내에서는 처음으로 고려된 항 목으로 교통사고 피해자 및 가족의 물질적·정신적 피해비용을 의미한다. 본연구에서는 각 항목의 비용 추계를 가능한 한 종합적이고 체계적이며 구체적으로 산출하였으며 그결과 사고등급별 건당 교통사고비 용을 도출하였다. PGS를 고려하지 않은 경우 사망사고 1건당 2억4천만원이고 중상사고 1건당 2천3백만 원 경상사고 1건당 7백 9십만원으로 추정되었다. 또한 사망자와 부상자 1인당 평균사고비용은 각각 2억 1천만원과 1천1백만원으로 나타났다.

• The Journal of the Convergence on Culture Technology
• /
• v.5 no.4
• /
• pp.137-145
• /
• 2019

Among the participants of the 2012 Korea Medical Panel survey, 308 people who have used emergency, hospitalization and outpatient services for cancer have been selected. The average annual direct cost per cancer patient was analyzed by adding up the patient's medical expenses, industrial copayments, and non-salary costs. The average annual direct direct cost of cancer spent by cancer patients is about 129,093,792 per male, 158,100,612 won for men and 110,482,075 for women.For those with health insurance, the total direct cost per person from cancer was 183,095,125 won and the beneficiaries were 46,241,705 won. By household income, the average annual direct direct costs per person were 112,459,971 won per patient in the household income quartile, 137,910,890 won for patients in the second quartile, 149,556,570 won in the third quartile and 112,730,461 won, quartile 5, respectively.Was 142,926,331 won.

• The Korean Society of Law and Medicine
• /
• v.15 no.1
• /
• pp.335-373
• /
• 2014

According to one Medicare report, in the US, total federal spending on health care expends almost 18 percent of the nation's GDP, about double what most industrialized nations spend on health care. And in 2011, Medicare spending reached close to $554 billion, which amounted to 21 percent of the total spent on U.S. health care in that year. Of that $554 billion, Medicare spent 28 percent, or about $170 billion, on patients' last six months of life. So what are the reasons of this high cost in EOL care and its possible solutions? Much spendings of Medicare on End-of-Life care for the terminally ill/chronically ill in the US has led health economics experts to assess the characteristics of the care. Decades of study shows that EOL care is usually supply-sensitive and poor in cost-effectiveness. The volume of care is sensitively depending on the supply of resources, rather than the severity of illness or preferences of patients. This means at the End-of-Life care, the medical resources are being overused. On the other hand, opposed to the common assumption, "The more care the better utility", the study shows that the outcome is very poor. Actually the patient preference and concerns are quite the opposite from what intense EOL care would bring about. This study analyzes the reasons for the supply-sensitiveness of EOL care. It can be resulted from the common misconception about the intense care and the outcome, physicians' mission for patients, lack of End-of-Life Care Decision which helps the patients choose their own preferred treatment intensity. It also could be resulted from physicians' fear of legal liabilities, and the management strategy since the hospitals are also seeking for financial benefits. This study suggests the possible solutions for over-treatment at the End-of-Life resulting from supply-sensitiveness. Solutions can be sought in two aspects, legal implementation and management strategy. In order to implement advance directive properly, active ethics education for physicians to change their attitude toward EOL care and more conversations about end-of-life care between physicians and patients is crucial, and incentive system for the physicians who actively have the conversations with patients will also help. Also, the general education towards the public is also important in the long run, and easy and official advance directive registry system-such as online registry-has to be built and utilized more widely. Alternative strategies in management are also needed. For example, the new strategic cost management and management education, such as cutting unnecessary costs and resetting values as medical providers have to be considered. In order to effectively resolve the problem in EOL care for the terminally ill/chronically ill and provide better experience to the patients, first of all, the misconception and the wrong conventional wisdom among doctors, patients, and the government have to be overcome. And then there should be improvements in systems and cultures of the EOL care.

• 건강소식
• /
• v.34 no.11
• /
• pp.42-43
• /
• 2010

우리나라 장기기증자는 선진국에 비교해 크게 부족하다. 이로 인해 실낱같은 희망을 걸고 장기이식 순서를 기다리는 대기자는 매년 증가하고 있다. 장기기증은 간이나 신장질환자의 치료에 투입되는 엄청난 의료비용을 줄여준다. 생명나눔 차원뿐만 아니라 사회적 비용 감소에도 기여하는 것이다. 외국의 장기기증 현황을 알아봄으로써 국내 적용 가능성을 점쳐보고자 한다.

• Journal of Food Hygiene and Safety
• /
• v.36 no.1
• /
• pp.68-76
• /
• 2021

Foodborne outbreaks frequently occur worldwide and result in huge economic losses. It is the therefore important to estimate the costs associated with foodborne diseases to minimize the economic damage. At the same time, it is difficult to accurately estimate the economic loss from foodborne disease due to a wide variety of cost components. In Korea, there are a limited number of analytical studies attempting to estimate such costs. In this study we investigated the components of economic cost used in foreign countries to better estimate the cost of foodborne disease in Korea. Seven recent studies investigated the cost components used to estimate the cost of foodborne disease in humans. This study categorized the economic loss into four types of cost: direct costs, indirect costs, food business costs, and government administration costs. The healthcare costs most often included were medical (outpatient) and hospital costs (inpatient). However, these cost components should be selected according to the systems and budgets of medical services by country. For non-healthcare costs, several other studies considered transportation costs to the hospital as an exception to the cost of inpatient care. So, further discussion is needed on whether to consider inpatient care costs. Among the indirect costs, premature mortality, lost productivity, lost leisure time, and lost quality of life/pain, grief and suffering costs were considered, but the opportunity costs for hospital visits were not considered in any of the above studies. As with healthcare costs, government administration costs should also be considered appropriate cost components due to the difference in government budget systems, for example. Our findings will provide fundamental information for economic analysis associated with foodborne diseases to improve food safety policy in Korea.

• Journal of the Korean hospital association
• /
• v.13 no.11 s.119
• /
• pp.28-31
• /
• 1984

국민을 위한 복지제도의 운용에는 어느나라나 막론하고 지대한 관심과 이해가 교차되고 있는 듯 하다 나라마다 지향하는 정책방향이나 국가 재원에 의해 다소 차이는 있겠지마는, 국민 각자의 건강과 연계되는 의료복지 제도의 정착을 위한 보건비용조달체계는 제도운영의 묘와 함께 주요한 관심사라 하겠으며 나라마다 그 체재 또한 서로 상이할 것이다. 본 고는 이러한 견지에서 자연의 혜택으로 부를 누리는 "쿠웨이트"의 보건비용조달체제를 고찰하므로써 타국의 보건의료제도와 접해보는 기회를 갖고자 소개하는 바이다.